AngioDynamics

AngioDynamics, Inc. designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat PVD, tumors, and other non-coronary diseases. The company operates in two divisions, Vascular and Oncology/Surgery. The Vascular division provides venous products, including VenaCure EVLT laser systems and Sotradecol; angiographic products and accessories comprising angiographic catheters, entry needles, guidewires, and fluid management products; percutaneous transluminal angioplasty dilation balloon catheters, such as WorkHorse, WorkHorse II, and Profiler to open blocked blood vessels and dialysis access sites; drainage products consisting of the total abscession general, biliary, and nephrostomy drainage catheters; and thrombolytic products that include pulsespray infusion and unifuse thrombolytic catheters, and speedlyser to deliver thrombolytic agents. It also offers micro access sets that provide interventional physicians a smaller introducer system for minimally-invasive procedures; Benephit, a therapeutic approach to deliver drugs directly to the kidneys; and various dialysis catheters, which comprise DuraMax, Schon, Evenmore, Dura-Flow, SCHON XL, LifeJet, and Centros dialysis catheters. In addition, this division provides PICC products consisting of Morpheus CT PICC, Morpheus CT PICC insertion kits, and Morpheus smart PICC; port products and accessories, including Vortex, SmartPort, and LifeGuard; and central venous catheter products. The Oncology/Surgery division offers radiofrequency ablation, embolization, and nanoknife products. The company markets its products to interventional radiologists, vascular surgeons, and surgical oncologists through a direct sales force in the United States and through a combination of direct sales and distributor relationships internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.